abstract |
REFERRED TO AN ANALGESIC PHARMACEUTICAL COMPOSITION, IN THE FORM OF A PARENTERAL UNIT DOSAGE OR IN THE FORM OF A UNIT DOSAGE FOR MUCOSA OR DERMIS, WHICH INCLUDES BUPRENORPHINE (N-CYCLOPROPYLMETIL-7 [ALFA] - [1- (S)-1,2 , 2-TRIMETHYL-PROPYL] 6,14-ENDOETAN-6,7,8,14-TETRAHIDRONORORIPAVINE) AND NALOXONE (1-N-ALYL-14-HYDROXINORHIDRO-MORPHINONE), WHERE BUPRENORPHINE IS FOUND IN A AMOUNT OF 10 uG AND 8 MG |